TMC Life Sciences Malaysia 3rd-Quarter 2026 Earnings Summary Table

Dow Jones
May 20
 
      TMC Life Sciences (0101.KU) - Malaysia 
      (3rd) quarter ended Mar 31: 
      Figures Are In Ringgit (MYR). 
 
 
                                   2026               2025 
 
Revenue                      89,701,000         89,872,000 
PreTax Profit                 2,749,000             52,000 
Net Profit                    1,758,000           -806,000 
Earnings Per Share             0.10 Sen          -0.05 Sen 
Dividend                       0.00 Sen           0.00 Sen 
 
      9 months ended Mar 31: 
 
Revenue                     293,675,000        252,265,000 
PreTax Profit                18,653,000          4,018,000 
Net Profit                   12,732,000          1,183,000 
Earnings Per Share             0.73 Sen           0.07 Sen 
Dividend                       0.00 Sen           0.00 Sen 
 
 
 

(END) Dow Jones Newswires

May 20, 2026 05:46 ET (09:46 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10